Related Experiment Video

Updated: Dec 10, 2025

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.9K

Progress in immunotherapy for small cell lung cancer

Dong Zhao1, Bing Xie1, Yong Yang1

  • 1Department of Oncology, The People's Hospital of Lixin County, Bozhou 236700, Anhui Province, China.

World Journal of Clinical Oncology
|September 3, 2020
PubMed

Insights

This review covers recent advances in immunotherapy for small-cell lung cancer (SCLC), an aggressive neuroendocrine tumor. Immunotherapy is emerging as a key treatment strategy following traditional radiotherapy and chemotherapy for SCLC patients.

Area of Science:

  • Oncology
  • Immunology
  • Medical Research

Background:

  • Small-cell lung cancer (SCLC) is a highly aggressive neuroendocrine tumor.
  • Current SCLC treatment relies mainly on radiotherapy and chemotherapy.
  • Targeted therapies for SCLC with driver mutations show limited progress.

Purpose of the Study:

  • To review recent advancements in immunotherapy for small-cell lung cancer.
  • To highlight immunotherapy's growing role in SCLC treatment paradigms.

Main Methods:

  • Literature review of recent research on SCLC immunotherapy.
  • Analysis of clinical trial data and preclinical findings.
  • Examination of antiangiogenic tyrosine kinase inhibitors' role.

Main Results:

  • Immunotherapy is increasingly recognized as a vital treatment strategy for SCLC.
  • Research on targeted therapies and antiangiogenic tyrosine kinase inhibitors (e.g., anlotinib) shows some success.
  • Significant progress has been made in developing novel immunotherapeutic approaches for SCLC.

Conclusions:

  • Immunotherapy represents a promising frontier in managing small-cell lung cancer.
  • Further research is crucial to optimize immunotherapy efficacy and integration with existing treatments for SCLC.
Keywords:
Cytotoxic T lymphocyte-associated antigen-4 inhibitorsPoly adenosine diphosphate ribose polymerase inhibitorsProgrammed death-1 inhibitorsSmall-cell lung cancer

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

1.5K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

17.9K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
857